With an increasing prevalence during the past decades, atopic dermatitis has become a
global health issue. A literature search following a targeted approach was undertaken to …

Atopic dermatitis is a chronic inflammatory skin condition that affects approximately 18
million people in the United States. Assessing the extent and severity of atopic dermatitis is …

Background Ruxolitinib (RUX) cream demonstrated potent anti-inflammatory and antipruritic
efficacy in a phase 2 study in adults with atopic dermatitis (AD). Objective To evaluate 8 …

Background Nemolizumab is a subcutaneously administered humanized monoclonal
antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in …

Atopic dermatitis (AD) is one of the most common inflammatory skin diseases. AD is driven
by barrier dysfunction and abnormal immune activation of T helper (Th) 2, Th22, and varying …

Background Bleach bathing is frequently recommended to treat atopic dermatitis (AD), but its
efficacy and safety are uncertain. Objective To systematically synthesize randomized …

Background Atopic dermatitis (AD) commonly occurs in children and can progress into
severe phenotypes or atopic march, causing significant impairment in quality of life. It is …

During the last years, numerous studies have described the presence of significant gut and
skin dysbiosis in some dermatological diseases such as atopic dermatitis, psoriasis and …

Background Atopic dermatitis (AD) is a common chronic, inflammatory skin condition. The
pathogenesis of AD involves many cytokines that utilize the Janus kinase/signal transducer …

There is a tremendous need for accurate and reproducible scoring systems for the grading
of skin disease to further the development of research and standards of care. There are …